Showing results (131-140 of 313) with videos related to
Sort By:
Pageof 32
Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of bisantrene in malignant lymphomas. A Southwest Oncology Group StudyT P Miller, J D Cowan, B A Neilan, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 1, 1995
Immunosuppression by conditioned media derived from a cloned choriocarcinoma cell line in serum-supplemented and defined mediaW A Bennett, M N Brackin, C A Long, et al.Journal of Assisted Reproduction and Genetics|March 1, 1995
Progesterone concentration as a predictor of pregnancy normalcy is the most useful when hCG levels are less than 2000 mIU/mLC A Long, S R Lincoln, N S Whitworth, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|June 1, 1990
Hydatidiform mole pregnancy trophoblast extracts differentially suppress interleukin-2-induced proliferation of human T-lymphocytes and PHA-blastsW A Bennett, M N Brackin, R P McGehee, et al.Human Biology|July 8, 2000
Gravidity and parity in postmenopausal American Indian women: the Strong Heart StudyK E North, J W MacCluer, L D Cowan, et al.American Journal of Obstetrics and Gynecology|May 29, 2004
Leukemia inhibitory factor and homeobox a10 gene expression in an ectopic pregnancy model for implantationMissy J McMinn, Randall S Hines, Rana B Walley, et al.American Journal of Obstetrics and Gynecology|June 1, 1992
Receiver-operator characteristic, efficiency analysis, and predictive value of serum progesterone concentration as a test for abnormal gestationsB D Cowan, D T Vandermolen, C A Long, et al.Fertility and Sterility|October 1, 1989
Bromocriptine inhibition of anesthesia-induced hyperprolactinemia: effect on serum and follicular fluid hormones, oocyte fertilization, and embryo cleavage rates during in vitro fertilizationV M Sopelak, N S Whitworth, P F Norman, et al.Journal of Reproductive Immunology|March 1, 1989
Suppression of lymphocyte proliferation in vitro by macromolecules in the vesicle fluid and tissue extracts of hydatidiform moleB D Cowan, W A Bennett, M N Brackin, et al.Fertility and Sterility|September 1, 1995
Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cyclesC A Long, V M Sopelak, S R Lincoln, et al.Pageof 32